Literature DB >> 2783773

Introduction of a Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth inhibitory effects of TGF-beta.

K A Houck1, G K Michalopoulos, S C Strom.   

Abstract

Growth of rat liver epithelial cells (RLEC) and primary cultures of parenchymal hepatocytes is potently inhibited by TGF-beta. Transfection of a mutated Ha-ras oncogene, but not a human c-myc oncogene, into RLEC resulted in cell lines resistant to growth inhibition by TGF-beta under anchorage-dependent conditions. Infection of primary rat hepatocyte cultures with v-Ha-ras yielded a cell line likewise insensitive to inhibition by TGF-beta. Binding of [125I]TGF-beta to Ha-ras-transfected RLEC was reduced relative to control or c-myc-transfected cells. These data suggest that activation of a Ha-ras oncogene in epithelial cells may result in escape from negative growth control and hence be a critical step during carcinogenesis. However, although Ha-ras induced resistance to growth inhibition by TGF-beta under anchorage-dependent conditions, TGF-beta inhibited the spontaneous growth in soft agar of all cell lines containing the Ha-ras oncogene. This may reflect an alteration in regulation of extracellular matrix proteins and related enzymes responsible for anchorage-independent growth.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783773

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.

Authors:  M Kretzschmar; J Doody; I Timokhina; J Massagué
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

2.  Subculture of proliferating adult rat hepatocytes in medium supplemented with nicotinamide and EGF.

Authors:  T Mitaka; T Kojima; T Mizuguchi; Y Mochizuki
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-09       Impact factor: 2.416

3.  Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF.

Authors:  R S Lo; D Wotton; J Massagué
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

4.  Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells.

Authors:  M Arsura; F Mercurio; A L Oliver; S S Thorgeirsson; G E Sonenshein
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

5.  H-ras-transformed NRK-52E renal epithelial cells have altered growth, morphology, and cytoskeletal structure that correlates with renal cell carcinoma in vivo.

Authors:  C J Best; L R Tanzer; P C Phelps; R L Merriman; G G Boder; B F Trump; K A Elliget
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-04       Impact factor: 2.416

6.  Ras-mediated suppression of TGFbetaRII expression in intestinal epithelial cells involves Raf-independent signaling.

Authors:  N M Bulus; H M Sheng; N Sizemore; S M Oldham; J V Barnett; R J Coffey; D R Beauchamp; J A Barnard
Journal:  Neoplasia       Date:  2000 Jul-Aug       Impact factor: 5.715

Review 7.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

8.  Transforming growth factor-beta (TGF-beta) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-beta.

Authors:  S B Jakowlew; J E Mead; D Danielpour; J Wu; A B Roberts; N Fausto
Journal:  Cell Regul       Date:  1991-07

9.  Spontaneous neoplastic transformation of WB-F344 rat liver epithelial cells.

Authors:  M J Hooth; W B Coleman; S C Presnell; K M Borchert; J W Grisham; G J Smith
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

10.  Neutralizing antibodies against transforming growth factor beta potentiate the proliferation of Ki-1 positive lymphoma cells. Further evidence for negative autocrine regulation by transforming growth factor beta.

Authors:  S R Newcom; K K Tagra; M E Kadin
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.